Linoleic acid
Also called: LA, omega-6 linoleic acid, C18:2n-6
An omega-6 polyunsaturated fatty acid (C18:2n-6). With alpha-linolenic acid it is one of the two essential fatty acids, which must be obtained from the diet. Major trials supplied it as corn or safflower oil and margarines made from them.
- Category
- Fatty acid
- Forms
- Linoleic acid, studied mainly as linoleic-acid-rich vegetable oils (corn oil, safflower oil) and polyunsaturated margarines made from them
- Strongest evidence
- A Strong
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2018 Cochrane review included 19 RCTs (6,461 participants) of higher versus lower omega-6 fat intake for at least 12 months; 12 assessed linoleic acid and 7 gamma-linolenic acid. The omega-6 fats usually displaced dietary saturated or monounsaturated fats. [2]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
AHeart and blood vessels4 topics
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| All-cause mortality and cardiovascular events | C | A 2018 Cochrane review found low-quality evidence that more omega-6 fat (12 of 19 trials tested linoleic acid) makes little or no difference to all-cause mortality (10 trials, 4,506 people) or cardiovascular events (7 trials). [2] |
| Blood lipids (omega-6 fats overall) | A | The 2018 Cochrane review found high-quality evidence that more omega-6 fat lowers total cholesterol a little (mean -0.33 mmol/L; 10 trials, 4,280 people), with little or no difference in triglycerides, HDL or LDL. [2] |
| Replacing saturated fat with linoleic-acid-rich corn oil (Minnesota Coronary Experiment, 1968-73) | C | Recovered data from this double-blind RCT (9,423 adults) showed lower serum cholesterol but no mortality benefit; each 30 mg/dL cholesterol reduction was associated with a 22% higher risk of death. [3] |
| Men after a coronary event: safflower-oil linoleic acid replacing saturated fat (Sydney Diet Heart Study, 1966-73) | C | Recovered data from this RCT (458 men) showed higher death rates with linoleic acid than controls (all-cause 17.6% vs 11.8%; hazard ratio 1.62, 95% CI 1.00 to 2.64). [4] |
Main constituents: Linoleic acid (C18:2n-6), one of the major omega-6 fatty acids [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Minnesota Coronary Experiment: a serum-cholesterol-lowering diet replaced saturated fat with linoleic acid from corn oil and corn oil polyunsaturated margarine. [3]
- Sydney Diet Heart Study: saturated fats were replaced with linoleic acid from safflower oil and safflower oil polyunsaturated margarine. [4]
- Cochrane-included trials followed participants for one to eight years. [2]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- In the Sydney Diet Heart Study, men with a recent coronary event who replaced saturated fat with safflower-oil linoleic acid had higher rates of death from all causes, cardiovascular disease and coronary heart disease than controls. [4]
- In the Minnesota Coronary Experiment, there was a 22% higher risk of death for each 30 mg/dL (0.78 mmol/L) reduction in serum cholesterol (hazard ratio 1.22, 95% CI 1.14 to 1.32). [3]
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [5]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Linoleic acid (C18:2n-6) Fatty acids and lipids (omega-6 polyunsaturated fatty acid) [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming linoleic acid was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-30). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. Entries naming conjugated linoleic acid (CLA), a different ingredient, were not counted. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
- NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-24 per page metadata), 2026-10-24. ods.od.nih.gov
Sources
- NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-24 per page metadata), 2026-10-24. ods.od.nih.gov
- Hooper L, et al. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2018, CD011094 (PubMed abstract) (PMID 30488422), 2018-11-29. pubmed.ncbi.nlm.nih.gov
- Ramsden CE, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ 2016;353:i1246 (PMID 27071971), 2016-04-12. pubmed.ncbi.nlm.nih.gov
- Ramsden CE, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013;346:e8707 (PMID 23386268), 2013-02-04. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in fatty acid: Algal oil (DHA and EPA) · Arachidonic acid · Argan oil · Conjugated linoleic acid (CLA) · Evening primrose oil · GLA oils (borage and blackcurrant seed oil) · Krill oil · MCT oil (medium-chain triglycerides) · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.